Orthox is a medical device company founded to exploit FibroFix, a novel silk-based biomaterial platform, for the repair of injuries to cartilage and bone. FibroFix combines exceptional strength and resilience with a porous architecture and chemical structure similar to Fibronectin, an essential component of human cartilage. Orthox believes these properties will allow FibroFix™ to act as both an immediate functional replacement for damaged cartilage, and a long term regenerative repair solution.

Regenerative biomaterials offer orthopaedic surgeons an alternative to the functional ‘heavy metal’ joint replacement technologies and corrective surgical interventions, allowing orthopaedic tissue to be supplemented and restored rather than simply excised or replaced with a prosthetic.